Cerebral Antibiotics Distribution After Acute Brain Injury

NCT ID: NCT01059890

Last Updated: 2016-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacterial Infection Brain Injury

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cefotaxime

Group Type EXPERIMENTAL

cefotaxime

Intervention Type DRUG

Metrodinazole

Group Type EXPERIMENTAL

Metronidazole

Intervention Type DRUG

Ciprofloxacine

Group Type EXPERIMENTAL

Ciprofloxacin

Intervention Type DRUG

Fosfocine

Group Type EXPERIMENTAL

Fosfocine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cefotaxime

Intervention Type DRUG

Metronidazole

Intervention Type DRUG

Ciprofloxacin

Intervention Type DRUG

Fosfocine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute brain injury
* Patient who receive an antibiotic for an infection or prophylaxy
* Glasgow coma score \< 8

Exclusion Criteria

* Age \< 18 years old
* Pregnant woman
* HCV, HIV, HBV infection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poitiers University Hospital

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Poitiers University Hospital - 2 rue de la Milétrie - Réanimation chirugicale

Poitiers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A-BRAIN

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Physiologic Study of Cerebral Perfusion
NCT02744625 COMPLETED PHASE4